Sensei Biotherapeutics, Inc. (SNSE) Social Stream



Sensei Biotherapeutics, Inc. (SNSE): $0.45

0.02 (+4.63%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add SNSE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#104 of 335

in industry

SENSEI BIOTHERAPEUTICS INC (SNSE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering SENSEI BIOTHERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $30 $12 $18 $0.73 2365.75%
2022-03-10 3 $12 $10 $11 $0.73 1406.85%
2022-05-11 3 $12 $4 $8 $0.73 995.89%
2022-08-09 2 $4 $4 $4 $0.73 447.95%
2022-10-03 2 $5 $4 $4.5 $0.73 516.44%
2023-01-05 2 $6 $4 $4.666 $0.73 539.18%
2023-09-27 2 $6 $4 $5 $0.73 584.93%
2023-12-04 3 $4 $4 $4 $0.73 447.95%

The Trend in the Analyst Price Target


Over the past 27 months, SNSE's average price target has gone down $8.

Over the past 48 weeks, SNSE's average upside potential has been 343.8%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-21 3 6 4 4.666 1.42 228.59%
2023-03-28 3 6 4 4.666 1.32 253.48%
2023-05-09 2 6 4 5.000 1.54 224.68%
2023-09-27 3 6 4 5.000 0.79 532.91%
2023-09-27 2 6 4 5.000 0.79 532.91%

SNSE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 31 weeks, SNSE's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, SENSEI BIOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1351.4% of them.
  • SENSEI BIOTHERAPEUTICS INC's number of analysts covering the stock is greater than 98.65% of all US stocks.
  • SNSE has a higher average analyst price target than 127.75% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SENSEI BIOTHERAPEUTICS INC's variance in analysts' estimates is lower than -231.49% of them.

Stocks similar to SENSEI BIOTHERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PHVS, CNTB, and EWTX.

Make investment decisions regarding SNSE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!